PNH cells are as sensitive to T‐cell‐mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria

No abstract is available for this paper.

• Publication year

  2000

• Venue

  British Journal of Haematology

• Publication date

  2000-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1365-2141.2000.02494.xPMID 11167756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paroxysmal nocturnal haemoglobinuria

  2017cited by this paper
• IMPLICATIONS OF RECENT INSIGHTS INTO THE PATHOPHYSIOLOGY OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

  2000cited by this paper
• The molecular basis of paroxysmal nocturnal hemoglobinuria.

  2000cited by this paper
• Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene.

  1999cited by this paper
• Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals.

  1999cited by this paper
• Different roles of glycosylphosphatidylinositol in various hematopoietic cells as revealed by a mouse model of paroxysmal nocturnal hemoglobinuria.

  1999cited by this paper
• Cytotoxicity against lymphoblastoid cells mediated by a T‐cell clone from an aplastic anaemia patient: role of CD59 on target cells

  1999cited by this paper
• The natural history of paroxysmal nocturnal hemoglobinuria.

  1997cited by this paper
• The dual pathogenesis of paroxysmal nocturnal hemoglobinuria

  1997cited by this paper
• The pathophysiology of acquired aplastic anemia.

  1997cited by this paper
• The structure and ligand interactions of CD2: implications for T-cell function.

  1996cited by this paper
• Mutations in the PIG-A gene causing paroxysmal nocturnal hemoglobinuria are mainly of the frameshift type.

  1995cited by this paper
• Natural history of paroxysmal nocturnal hemoglobinuria.

  1995cited by this paper
• The molecular basis of paroxysmal nocturnal hemoglobinuria.

  1995cited by this paper
• CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation.

  1994cited by this paper
• Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood.

  1994cited by this paper
• Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria.

  1994cited by this paper
• A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice

  1993cited by this paper
• Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.

  1993cited by this paper
• Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.

  1992cited by this paper
• Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59.

  1992influential reference
• The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated.

  1992cited by this paper
• Distinct restriction of complement- and cell-mediated lysis.

  1989cited by this paper
• 7 Paroxysmal nocturnal haemoglobinuria

  1989cited by this paper
• Paroxysmal nocturnal haemoglobinuria.

  1989cited by this paper
• Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface

  1987cited by this paper
• The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3

  1987influential reference

• Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria.

  2025cites this paper
• Leukemic transformation during anti-tuberculosis treatment in aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome: A case report and review of literature

  2023cites this paper
• Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease

  2020cites this paper
• Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria

  2018cites this paper
• Recent advances in pathogenesis of paroxysmal nocturnal hemoglobinuria

  2015cites this paper
• Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia

  2014cites this paper
• killer cells in vitro Decreased susceptibility of leukemic cells with PIG-Amutation to natural

  2013cites this paper
• Effects of Lactobacillus gasseri OLL2809 and α-lactalbumin on university-student athletes: a randomized, double-blind, placebo-controlled clinical trial.

  2013cites this paper
• T cells expressing the activating NK-cell receptors KIR2DS4, NKG2C and NKG2D are elevated in paroxysmal nocturnal hemoglobinuria and cytotoxic toward hematopoietic progenitor cell lines.

  2011cites this paper
• Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.

  2009cites this paper
• The role of Wilms' tumor gene peptide-specific cytotoxic T lymphocytes in immunologic selection of a paroxysmal nocturnal hemoglobinuria clone.

  2007cites this paper
• Targeted therapy for inherited GPI deficiency.

  2007cites this paper
• Heterogeneity in the Molecular Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria (PNH) Syndromes and Expansion Mechanism of a PNH Clone

  2006cites this paper
• Pathophysiologic mechanisms in acquired aplastic anemia.

  2006cites this paper
• Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency

  2006cites this paper
• Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP.

  2006cites this paper
• Current concepts in the pathophysiology and treatment of aplastic anemia.

  2006cites this paper
• Flow cytometric analysis of CD 55 and CD 59 expression on blood cells in paroxysmal nocturnal haemoglobinuria

  2005cites this paper
• IMMUNOSELECTION OF PIG-A MUTANT CELLS MISSING ULBP

  2005cites this paper
• Flow cytometric analysis of CD55 and CD59 expression on blood cells in paroxysmal nocturnal haemoglobinuria.

  2005cites this paper
• Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors.

  2005cites this paper
• Frequent HPRT mutations in paroxysmal nocturnal haemoglobinuria reflect T cell clonal expansion, not genomic instability

  2004cites this paper
• In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation.

  2004cites this paper
• Anti‐thymocyte globulin treatment of marrow aplasia associated with paroxysmal nocturnal haemoglobinuria (PNH) resulted in haematological improvement due to an expansion of the PNH clone

  2003cites this paper
• Pathogenesis of Selective Expansion of PNH Clones

  2003cites this paper
• Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.

  2002cites this paper
• Seeing the good and bad in aplastic anemia: is autoimmunity in AA dysregulated or antineoplastic?

  2002cites this paper
• Decreased susceptibility of leukemic cells with PIG-A mutation to natural killer cells in vitro.

  2002cites this paper
• Paroxysmal nocturnal hemoglobinuria: Differential gene expression of EGR-1 and TAXREB107.

  2002cites this paper
• Glycosylphosphatidylinositol‐linked proteins are required for maintenance of a normal peripheral lymphoid compartment but not for lymphocyte development

  2002cites this paper
• Relationship Between Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria

  2002cites this paper
• Views on the pathophysiology of aplastic anaemia

  2002cites this paper
• The cellular pathogenesis of paroxysmal nocturnal haemoglobinuria

  2001cites this paper